Research Paper Volume 13, Issue 24 pp 25920—25930
LDH-A inhibitors as remedies to enhance the anticancer effects of PARP inhibitors in ovarian cancer cells
Figure 4. Oxamate enhanced the tumor suppression effect of PARP inhibitors on ovarian cancer cells. (A–D) Tumor volumes of xenograft tumor with oxamate and/or PARP inhibitors (olaparib or AG14361) treatment. (E–H) Survival time of xenograft tumor models with oxamate and/or PARP inhibitors (olaparib or AG14361) treatment were recorded. Mean ± SEM, *P < 0.05, **P < 0.01, ns: no significance.